Hyperspectral imaging as an objective diagnostic tool for secondary lymphedema in breast cancer patients
Hyperspectral imaging provides reproducible, objective, and noninvasive assessment of secondary lymphedema. These findings support its potential as a diagnostic and monitoring tool to improve staging and treatment evaluation.
Authors
- Ovidiu F. Jurjuţ (ORCID: https://orcid.org/0009-0000-6169-9458)
- Lukas Schimunek
- Wiebke Eisler (ORCID: https://orcid.org/0009-0004-4659-5334)
- Martin Weiß (ORCID: https://orcid.org/0000-0001-8511-8339)
- Alexander R. Ehrhardt
- Adrien Daigeler (ORCID: https://orcid.org/0000-0002-0012-9870)
- Anna Seller (ORCID: https://orcid.org/0000-0003-0886-2177)
- Markus Hahn (ORCID: https://orcid.org/0000-0002-0284-6566)
- Mario Marx
- Anaclara Herholz
Institutions
- BG Klinik Tübingen (DE)
- Natural and Medical Sciences Institute (DE)
- Förderverein Institut für Medizintechnik Dresden (DE)
- University of Tübingen (DE)
Publication Details
- Journal
- Communications Medicine
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1038/s43856-025-01301-y
- Primary Topic
- Lymphatic System and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00